Nifedipine, trade name Baixintong, is a dihydropyridine calcium channel blocker that mainly blocks L-type calcium channels. Nifedipine is mainly used to treat angina pectoris, hypertension, Raynaud's syndrome and even premature birth. It is also often used to treat severe pregnancy-induced hypertension. Usually used on pregnant women with premature babies, steroids can have enough time to act, improve the lung condition of premature babies, and give the mother enough time to get better care.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Nifedipine industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Market Segment by Product Application
Primary Pulmonary Hypertension
Heart Failure
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Bayer (Germany)
Actavis (USA)
Teva (Israel)
Pfizer (USA)
Shyndec (China)
Honglin (China)
Huanghai (China)
Yabao (China)
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Nifedipine consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Nifedipine market by identifying its various subsegments.
3.Focuses on the key global Nifedipine manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Nifedipine with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Nifedipine submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Nifedipine Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Nifedipine Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Nifedipine Segment by Type
2.1.1 Nifedipine Controlled Release Tablets
2.1.2 Nifedipine Extended Action Tablets
2.2 Market Analysis by Application
2.2.1 Primary Pulmonary Hypertension
2.2.2 Heart Failure
2.2.3 Others
2.3 Global Nifedipine Market Comparison by Regions (2017-2027)
2.3.1 Global Nifedipine Market Size (2017-2027)
2.3.2 North America Nifedipine Status and Prospect (2017-2027)
2.3.3 Europe Nifedipine Status and Prospect (2017-2027)
2.3.4 China Nifedipine Status and Prospect (2017-2027)
2.3.5 Japan Nifedipine Status and Prospect (2017-2027)
2.3.6 Southeast Asia Nifedipine Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Nifedipine Industry Impact
2.5.1 Nifedipine Business Impact Assessment - Covid-19
2.5.2 Market Trends and Nifedipine Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Nifedipine Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Nifedipine Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Nifedipine Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Nifedipine Manufacturer Market Share
3.5 Top 10 Nifedipine Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Nifedipine Market
3.7 Key Manufacturers Nifedipine Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Nifedipine Industry Key Manufacturers
4.1 Bayer (Germany)
4.1.1 Compan Detail
4.1.2 Bayer (Germany) Nifedipine Product Introduction, Application and Specification
4.1.3 Bayer (Germany) 134 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Bayer (Germany) News
4.2 Actavis (USA)
4.2.1 Compan Detail
4.2.2 Actavis (USA) Nifedipine Product Introduction, Application and Specification
4.2.3 Actavis (USA) Nifedipine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Bayer (Germany) News
4.3 Teva (Israel)
4.3.1 Compan Detail
4.3.2 Teva (Israel) Nifedipine Product Introduction, Application and Specification
4.3.3 Teva (Israel) Nifedipine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Teva (Israel) News
4.4 Pfizer (USA)
4.4.1 Compan Detail
4.4.2 Pfizer (USA) Nifedipine Product Introduction, Application and Specification
4.4.3 Pfizer (USA) Nifedipine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Pfizer (USA) News
4.5 Shyndec (China)
4.5.1 Compan Detail
4.5.2 Pfizer (USA) Nifedipine Product Introduction, Application and Specification
4.5.3 Shyndec (China) Nifedipine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Shyndec (China) News
4.6 Honglin (China)
4.6.1 Compan Detail
4.6.2 Honglin (China) Nifedipine Product Introduction, Application and Specification
4.6.3 Honglin (China) Nifedipine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Honglin (China) News
4.7 Huanghai (China)
4.7.1 Compan Detail
4.7.2 Huanghai (China) Nifedipine Product Introduction, Application and Specification
4.7.3 Huanghai (China) Nifedipine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Yabao (China)
4.8.1 Compan Detail
4.8.2 Yabao (China) Nifedipine Product Introduction, Application and Specification
4.8.3 Yabao (China) Nifedipine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Yabao (China) News
5 Global Nifedipine Market Segment by Big Type
5.1 Global Nifedipine Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Nifedipine Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Nifedipine Revenue and Market Share by Big Type (2017-2022)
5.2 Nifedipine Controlled Release Tablets Sales Growth Rate and Price
5.2.1 Global Nifedipine Controlled Release Tablets Sales Growth Rate (2017-2022)
5.2.2 Global Nifedipine Controlled Release Tablets Price (2017-2022)
5.3 Nifedipine Extended Action Tablets Sales Growth Rate and Price
5.3.1 Global Nifedipine Extended Action Tablets Sales Growth Rate (2017-2022)
5.3.2 Global Nifedipine Extended Action Tablets Price (2017-2022)
6 Global Nifedipine Market Segment by Big Application
6.1 Global Nifedipine Sales Market Share by Big Application (2017-2022)
6.2 Primary Pulmonary Hypertension Sales Growth Rate (2017-2022)
6.3 Heart Failure Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Nifedipine Forecast
7.1 Global Nifedipine Revenue, Sales and Growth Rate (2022-2027)
7.2 Nifedipine Market Forecast by Regions (2022-2027)
7.2.1 North America Nifedipine Market Forecast (2022-2027)
7.2.2 Europe Nifedipine Market Forecast (2022-2027)
7.2.3 China Nifedipine Market Forecast (2022-2027)
7.2.4 Japan Nifedipine Market Forecast (2022-2027)
7.2.5 Southeast Asia Nifedipine Market Forecast (2022-2027)
7.2.6 Other Regions Nifedipine Market Forecast (2022-2027)
7.3 Nifedipine Market Forecast by Type (2022-2027)
7.3.1 Global Nifedipine Sales Forecast by Type (2022-2027)
7.3.2 Global Nifedipine Market Share Forecast by Type (2022-2027)
7.4 Nifedipine Market Forecast by Application (2022-2027)
7.4.1 Global Nifedipine Sales Forecast by Application (2022-2027)
7.4.2 Global Nifedipine Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Nifedipine Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Nifedipine Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Nifedipine
Figure Market Concentration Ratio and Market Maturity Analysis of Nifedipine
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Nifedipine Market Size by Big Type
Figure Global Market Share of Nifedipine by Big Type in 2021
Figure Nifedipine Controlled Release Tablets Picture (2017-2022)
Global Nifedipine Market Size by Big Application
Table Global Nifedipine Market Size by Application
Figure Global Nifedipine Market Share by Big Application in 2021
Figure Primary Pulmonary Hypertension Picture
Figure Heart Failure Picture
Figure Others Picture
Table Global Nifedipine Comparison by Regions (M USD) (2017-2027?
Figure Global Nifedipine Market Size (Million US$) (2017-2027)
Figure North America Nifedipine Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Nifedipine Revenue (Million US$) Growth Rate (2017-2027)
Figure China Nifedipine Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Nifedipine Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Nifedipine Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Nifedipine Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Nifedipine Sales by Manufacturer (2017-2022)
Figure Global Nifedipine Sales Market Share by Manufacturer in 2021
Table Global Nifedipine Revenue by Manufacturer (2017-2022)
Figure Global Nifedipine Revenue Market Share by Manufacturer in 2021
Table Global Nifedipine Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Nifedipine Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Nifedipine Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Nifedipine Market
Table Key Manufacturers Nifedipine Product Type
Table Mergers & Acquisitions Planning
Table Bayer (Germany) Company Profile
Table Nifedipine Product Introduction, Application and Specification of Bayer (Germany)
Table Nifedipine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Actavis (USA) Company Profile
Table Nifedipine Product Introduction, Application and Specification of Actavis (USA)
Table Nifedipine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Actavis (USA) Recent Development
Table Teva (Israel) Company Profile
Table Nifedipine Product Introduction, Application and Specification of Teva (Israel)
Table Nifedipine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva (Israel) Main Business
Table Teva (Israel) Recent Development
Table Pfizer (USA) Company Profile
Table Nifedipine Product Introduction, Application and Specification of Pfizer (USA)
Table Nifedipine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer (USA) Main Business
Table Pfizer (USA) Recent Development
Table Pfizer (USA) Main Business
Table Pfizer (USA) Recent Development
Table Shyndec (China) Company Profile
Table Nifedipine Product Introduction, Application and Specification of Shyndec (China)
Table Nifedipine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shyndec (China) Main Business
Table Shyndec (China) Recent Development
Table Honglin (China) Company Profile
Table Nifedipine Product Introduction, Application and Specification of Honglin (China)
Table Nifedipine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Honglin (China) Main Business
Table Honglin (China) Recent Development
Table Huanghai (China) Company Profile
Table Nifedipine Product Introduction, Application and Specification of Huanghai (China)
Table Nifedipine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Huanghai (China) Main Business
Table Huanghai (China) Recent Development
Table Yabao (China) Company Profile
Table Nifedipine Product Introduction, Application and Specification of Yabao (China)
Table Nifedipine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Yabao (China) Main Business
Table Yabao (China) Recent Development
Figure Global Nifedipine Sales and Growth Rate (2017-2022)
Figure Global Nifedipine Revenue and Growth Rate (2017-2022)
Table Global Nifedipine Sales by Regions (2017-2022)
Figure Global Nifedipine Sales Market Share by Regions in 2021
Table Global Nifedipine Revenue by Regions (2017-2022)
Figure Global Nifedipine Revenue Market Share by Regions in 2021
Figure North America Nifedipine Sales and Growth Rate (2017-2022)
Figure Europe Nifedipine Sales and Growth Rate (2017-2022)
Figure China Nifedipine Sales and Growth Rate (2017-2022)
Figure Japan Nifedipine Sales and Growth Rate (2017-2022)
Figure Southeast Asia Nifedipine Sales and Growth Rate (2017-2022)
Figure Other Regions Nifedipine Sales and Growth Rate (2017-2022)
Table Global Nifedipine Sales by Big Type (2017-2022)
Table Global Nifedipine Sales Market Share by Big Type (2017-2022)
Figure Global Nifedipine Sales Market Share by Big Type in 2019
Table Global Nifedipine Revenue by Big Type (2017-2022)
Table Global Nifedipine Revenue Market Share by Big Type (2017-2022)
Table Global Nifedipine Revenue Market Share by Big Type in 2019
Figure Global Nifedipine Controlled Release Tablets Sales Growth Rate (2017-2022)
Figure Global Nifedipine Controlled Release Tablets Price (2017-2022)
Figure Global Nifedipine Extended Action Tablets Sales Growth Rate (2017-2022)
Table Global Nifedipine Sales by Big Application (2017-2022)
Table Global Nifedipine Sales Market Share by Big Application (2017-2022)
Figure Global Nifedipine Sales Market Share by Big Application in 2019
Figure Global Primary Pulmonary Hypertension Sales Growth Rate (2017-2022)
Figure Global Heart Failure Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Nifedipine Sales and Growth Rate (2022-2027)
Figure Global Nifedipine Revenue and Growth Rate (2022-2027)
Table Global Nifedipine Sales Forecast by Regions (2022-2027)
Table Global Nifedipine Market Share Forecast by Regions (2022-2027)
Figure North America Sales Nifedipine Market Forecast (2022-2027)
Figure Europe Sales Nifedipine Market Forecast (2022-2027)
Figure China Sales Nifedipine Market Forecast (2022-2027)
Figure Japan Sales Nifedipine Market Forecast (2022-2027)
Figure Southeast Asia Sales Nifedipine Market Forecast (2022-2027)
Figure Other Regions Sales Nifedipine Market Forecast (2022-2027)
Table Global Nifedipine Sales Forecast by Type (2022-2027)
Table Global Nifedipine Market Share Forecast by Type (2022-2027)
Table Global Nifedipine Sales Forecast by Application (2022-2027)
Table Global Nifedipine Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nifedipine
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Nifedipine Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Nifedipine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Nifedipine Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Nifedipine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Nifedipine Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Nifedipine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Nifedipine Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Nifedipine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Bayer (Germany)
Actavis (USA)
Teva (Israel)
Pfizer (USA)
Shyndec (China)
Honglin (China)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)